Product Information
CEFDINIR 300 MG CAPSULE is a generic product labeled by Ascend Laboratories, LLC, priced at $0.4593 per EA under NDC 67877054360. Its NADAC has been published 272 times since Jun 9, 2021.
FDA first approved this application on Feb 19, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877054360
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CEFDINIRApproval Type
Generic (ANDA)
FDA Application
ANDA210220FDA Approved
2/19/2021
TE Code
AB
On Market Since
2/20/2021
Pharmacological Classes
Price Statistics
The NADAC for CEFDINIR 300 MG CAPSULE has been published 272 times since Jun 9, 2021, and over the history we have for it it has declined 4.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4593 per EA |
|---|---|
| All-time high | $0.5647 (Aug 11, 2021) |
| All-time low | $0.3507 (Nov 20, 2024) |
| 52-week high | $0.4752 |
| 52-week low | $0.4551 |
| Median price | $0.4676 |
| Average price | $0.4657 |
| Largest weekly change | -25.5% (Nov 20, 2024) |
| Weeks tracked | 272 |
| Tracking since | Jun 9, 2021 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CEFDINIR 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CEFDINIR 300 MG CAPSULE, manufactured by Ascend Laboratories, LLC, is $0.4593 per EA (NDC 67877054360), effective Aug 19, 2026.
How has the price of CEFDINIR 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CEFDINIR 300 MG CAPSULE has declined 4.9%. It has been tracked across 272 weekly CMS publications since Jun 9, 2021.
What are the highest and lowest recorded NADAC prices for CEFDINIR 300 MG CAPSULE?
Since Jun 9, 2021, the NADAC for CEFDINIR 300 MG CAPSULE has ranged from a low of $0.3507 (Nov 20, 2024) to a high of $0.5647 (Aug 11, 2021), with a median of $0.4676 per EA.
Are there cheaper alternatives to CEFDINIR 300 MG CAPSULE?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CEFDINIR 300 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures CEFDINIR 300 MG CAPSULE?
CEFDINIR 300 MG CAPSULE (NDC 67877054360) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.